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Abstract 
The interaction between perazine dimaleate (PDM) and bovine serum albumin (BSA) was 
investigated by voltammetry, fluorescence spectroscopy, UV–vis spectroscopy, molecular 
docking and viscometric methods. The study was carried out in acetate buffer solution of 
pH 7.2, which was prepared by using 0.1 M sodium acetate and adjusting pH using 
0.1 M hydrochloric acid. The voltammetric study of PDM shows a pair of well redox 
peaks at 0.538 and 0.471 V (versus SCE) on a GCE in acetate buffer of pH 7.2 at  
50 mV s-1. After the addition of BSA into the PDM solution, the redox peak currents 
decreased gradually, and peak potentials shifted towards negative direction. The results 
of voltammetry, fluorescence quenching and UV–vis absorption spectra experiments 
indicated the formation BSA–PDM complex. The binding parameters like binding con-
stant and binding free energy were determined from voltammetric data. The binding 
constant and binding energy was also determined from UV–vis and fluorescence 
spectroscopy with a value quite close to that obtained from CV. 
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Introduction 
The drug–protein interaction is a fundamental issue in life process that helps us to understand 
the absorption, transport, metabolism and the target molecules of the drugs at the cellular level 
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[1-3]. Serum albumins are the major soluble protein constituents of the circulatory system 
possessing many physiological functions of which the most important are serving as a depot and a 
transport protein for many endogenous and exogenous compounds such as drugs [4]. The 
interaction of drugs with serum albumin is great aspect and various types of application in 
research field in chemistry, life science and clinical medicine [5-8]. Bovine serum albumin (BSA) has 
been widely investigated due to its structural homology with human serum albumin [9]. 
Intercalation, groove binding, and electrostatic interactions are the three major binding modes of 
small molecules to BSA [10].  
Perazine dimaleate (PDM) is biologically active drug, chemically known as 10-[3-(4 methylpipe-
razine-1-yl)propyl]-10-phenothiazine·2maleicacid; perazine maleate; Pernazinum (Fig. 1). PDM is 
important class of tricyclic compounds belongs to the phenothiazine family drugs. Generally, 
phenothiazine drugs are widely used as antiemetic, sedative and analgesic because they are able 
to reduce the side effects of chemotherapy and they they also have a role in inhibiting tumor cell 
proliferation. These drugs can also reduce anxiety, insomnia and other symptoms related to the 
psychological state of cancer patients [11]. 
 
Fig. 1. Chemical structure of perazine dimaleate (PDM) 
There has not any report about the study of PDM–BSA interaction based on the voltammetry 
behaviours at GCE and more than ever on the change of spectroscopic characteristics. Accordingly, 
in this work, investigations of the voltammetric behaviour of PDM upon addition of BSA were 
carried out. Moreover, the changes in the UV-Vis absorption and fluorescence emission when 
PDM binding to BSA were used to study the mode of such interaction. The results of voltammetry 
and spectroscopic techniques confirmed each other. The interaction study of PDM with BSA gives 
the information about the quenching mechanisms, binding constant, binding mode and number of 
binding sites. The advantage of this method is simple, rapid, accurate and inexpensive. 
Materials and methods 
PDM sample was donated by Global Calcium Ltd., Hosur. Stock solution, 1.0 mmol L-1 of PDM 
was prepared by dissolving an appropriate amount of the drug in doubly distilled water. BSA 
(Sigma–Aldrich) was used without further purification and its stock solution was prepared by 
dissolving an appropriate amount of BSA in doubly distilled water and stored at 4 °C. The 
concentration of BSA in stock solution was determined by UV absorption at 260 nm using a molar 
absorption coefficient ε260 = 66,000 L mol
-1 cm-1. Purity of the BSA was checked by monitoring the 
ratio of the absorbance at 260 nm to that at 280 nm [12]. The supporting electrolyte used for 
0.1 M acetate buffer solution of pH 7.2, which was prepared by using 0.1 M sodium acetate and 
pH was adjusted by using 0.1M acetic acid and all the experiments were conducted in this buffer 
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at 25 °C. All other reagents used were of analytical grade and doubly distilled water was used 
throughout the experiment.  
Instrumentation 
Voltammetric measurements were performed using a CH electrochemical analyzer. A 
conventional three-electrode cell was employed throughout the experiments, with glassy carbon 
electrode (3.0 mm diameter) as a working electrode, a saturated calomel electrode (SCE) as a 
reference electrode, and a platinum electrode as a counter electrode. 
Absorption spectra were measured on Ellico UV-visible spectrophotometer. The electronic 
spectrum of a known concentration of the drug was obtained without BSA. The spectroscopic 
response of the same amount of the drug was then monitored by the addition of small aliquots of 
BSA solution. All of the samples were mixed properly and allowed to equilibrate for 5 min prior to 
every spectroscopic measurement. 
The viscosity measurements were carried out using Ostwald viscometer. The pH measurements 
were made with Scott Gerate pH meter CG 804. An electronic thermostat water-bath was used for 
controlling the temperature.  
The steady-state fluorescence spectra were recorded using an F-2700 spectrofluorometer 
(Japan). The fluorescence emission spectrum of PDM (excitation at 250 nm) was used to obtain the 
intensities of the peaks. Good resolution of the bands was obtained at the slit width (ex. 10.0 nm; 
em.10.0 nm). The scan range used was from 300 to 600 nm. 
The molecular docking studies of BSA with compounds were achieved by using Auto dock Vina, 
developed at the Scripps research institute (http://vina.scripps.edu) [13]. The input files for 
AutoDock Vina were prepared with AutoDock Tools (ADT), which is a Graphical User Interface for 
AutoDock and AutoDock Vina. The crystal structure of bovine serum albumin (3V03) was retrieved 
from Protein data bank and the ligand binding site location was analyzed by Q-Site Finder [14]. The 
co-crystallized ligand was removed. Using ADT the water molecules were removed from the 
protein and polar hydrogen were added followed by adding Kollman charges. The Grid box has 
been set according to the binding site on protein and saved as pdbqt format, which was required 
by AutoDock Vina. The 2 dimensional structure of ligand were drawn by Chem sketch and 
converted to PDB format, required by AutoDock Tools by Open Babel [15]. The rotatable bonds 
were selected within the ligand using Choose Torsions option in ADT and saved in pdbqt format 
The Lamarckian Genetic Algorithm (LGA), which is a novel and robust automated docking method 
available in AutoDock [16], was employed. 
Results and discussion 
Voltammetric studies of interaction of PDM with BSA 
The Voltammetric behaviour of 1.5 x 10-4 M PDM in the absence and presence of BSA on bare 
GCE at 50mV s-1 is shown in Fig. 2. The voltammogram without BSA featured a couple of well 
defined and stable redox peaks in the potential range of 0.0 – 1.0 V. The anodic and cathodic 
peaks were appeared at 0.538 and 0.471 V vs. SCE with a formal potential (E0) of 0.5045 V. The 
formal potential (Eo) in all voltammetric studies, predictable as the midpoint of reduction and 
oxidation potentials. By the addition of 5 - 30 µmol L-1 of BSA into 1.5×10-4 M drug (Fig. 2) the 
anodic peak potential was shifted towards negative direction and also peak current was 
decreased. The substantial decrease in peak current indicates the formation of PDM–BSA complex. 
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E / V vs. SCE 
Fig. 2. Cyclic voltammogram of 1.5 x 10-4 M PDM in the absence of BSA and in presence of  
CBSA = 0, 5, 10, 15, 20, 25, 30 µmol L
-1 (a to g) BSA in acetate buffer of pH-7.2 at 50 mV s-1 and 
inset of the plot of log (1/[BSA]) vs. log (I/ (I0 −I)). 
The mode of PDM–BSA interaction can be well-known from the variation in formal potential. In 
general the positive shift (anodic shift) in formal potential is caused by the intercalation of the 
drug with BSA [17], while negative shift is observed for the electrostatic interaction of the drug 
with BSA [18]. Therefore, this is evident that negative peak potential shift (cathodic shift) in the CV 
behaviour of PDM by the addition of BSA is attributable to the electrostatic interaction of PDM 
with BSA. The cathodic peak potential shift further indicates that PDM is easier to oxidize in 
presence of BSA because its oxidized form is more strongly bound to BSA than its reduced form. In 
this system, both forms of the drug interact with BSA.  
Based upon the decrease in peak current of PDM by the various concentration of BSA, the 
binding constant was calculated according to the following equation [19]: 
log (1/[BSA]) = log K + log (I/I0-I)  
where, K is the binding constant, I0 and I are the peak currents of the free PDM and PDM–BSA 
complex, respectively. The plot of log (1/[BSA]) vs. log (I/(I0 −I)) constructed (inset of Fig. 2). From 
the linear fitting, the binding constant (K) can be estimated from the intercept. With this 
procedure, we obtained K = 4.591×104 L M-1 and the correlation coefficient was found as 0.99649. 
Influence of scan rate 
The voltammetric behavior of 1.5×10-4 M PDM in the absence and presence of BSA at bare GCE 
is shown in Fig. 3. The CVs of the 1.5×10-4 M PDM on GCE in 0.1 M acetate buffer solution at pH 7.2 
shows pair of well defined and stable redox peaks in the potential range of 0.0 – 1.0 V. An increase 
in the scan rate, peak potential does not shift but peak currents of both anodic as well as cathodic 
increased linearly. The scan rate varies from 10 to 400 mV s−1. At the same time, the cathodic and 
anodic peak currents increased linearly with the scan rate (Fig. 3) and the redox peak currents 
increased linearly with the scan rate, the correlation coefficient was 0.9919 for cathodic peak and 
0.9944 for anodic peak respectively. The redox process is diffusion-controlled as shown by Ipeak 
versus υ1/2 plot inset of Fig. 3. This was further confirmed by the plot of log Ipeak vs. log υ, which 
was linear within the same scan rate range and gave a slope of 0.5606 [Figure as not shown]. This 
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electrode process [20]. This phenomenon suggested that the redox process was a diffusion 
controlled and the PDM was stable. 
. 
E / V vs. SCE 
Fig. 3 Cyclic voltammograms of 1.5 x 10-4 M PDM at various scan rates: 10, 25, 50, 100, 200, 
400 mV s-1 respectively. Inset, plot of Ipeak versus υ
1/2 (Red and black points are before addition 
of BSA and blue and green points are after addition of BSA) 
The redox peak of PDM is attributed to the one electron which involved reduction and 









The electron transfer rate constant (ks) is calculated using Laviron’s equations [21-23] as 
follows: 
E = E0 – 2.3RT log (ν/αnF) 
E = E0 – 2.3RT log (ν/(1-α)nF) 
log ks = log(1-α) + (1-α) log α - log (RT/nFν) - α(1-α)nF∆Ep/2.303RT 
 
Where α is the electron transfer coefficient, n is the number of electrons transferred (n = 1).  
R = 8.314 J mol−1 K−1, T = 298 K and F = 96493 C/mol are gas, temperature and Faraday constant, 
respectively and ks is the electron transfer rate constant which can be calculated according to the 
plot of ΔEp versus ln ν. It is found to be 0.9890 s
-1 in absence of BSA and 1.101 s-1 in presence of 
BSA. From the results of the above experiments, the formation of an electrochemically non-active 
complex of PDM with BSA resulted in the decrease of the free concentration of PDM in the 
reaction solution which caused the decrease of the peak currents. There is no appreciable 
difference in the value of k0 in presence and absence of BSA indicating that BSA did not alter the 
voltammetric kinetics of PDM. 
Absorption spectral behaviour of PDM with BSA  
The UV-visible absorption titration is simple and more effective method for getting further 
clues about the mode of interaction and binding strength. Figure. 4 show the electronic absorption 
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absorbance of PDM was located around at 248 nm. The maximum absorption of the drug at this 
wavelength exhibited slight bathochromic shift and pronounce hyperchromic shifts by the 
incremental addition of BSA. The bathochromic shift is associated with the decrease in energy gap 
between the highest (HOMO) and lowest (LUMO) molecular orbitals after interaction of PDM to 
BSA [24]. The compactness in the structure of either the drug alone and/or BSA after the for-
mation of drug-BSA complex may result in hyperchromism. Meanwhile, PDM molecule is inserted 
into the cavities of BSA and disrupted the original structures of BSA. This results which confirms 









(1 / [BSA]) / M-1 
Figure. 4 UV-visible spectra of (A) PDM and BSA, (B) 1.5 x 10-4 M PDM in the absence of BSA 
and the presence of [BSA] =  5.0, 10.0, 15.0, 20.0, 25.0 and 30.0 µmol BSA in acetate buffer of 
pH 7.2. (C) The plot of (A0 / (A-A0) versus 1 / [BSA]. 
Based upon the increase in absorbance, the binding constant (Kb) was calculated according to 
the following equation [24].  
A0/(A-A0) = εG/(εH-G – εG) + εG/(εH-G - εG) x 1/K[BSA] 
Where, A0 and A are the absorbance of PDM in the absence and presence of BSA, εG and εH–G 
are the absorption coefficients of PDM and its complex with BSA, respectively. 
The slope to intercept ratio of the plot between A0/(A- A0) vs. 1 / [BSA] yielded the binding 
constant, K = 6.6671×104 L M-1, which is close to the value of K = 1.9824×104 L M-1 obtained from 
CV. The moderate binding constant indicative of electrostatic interaction and the Gibbs energy 
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change (ΔG = -RT ln K) of approximately 24.039 kJ mol-1 at 25 °C signifies the spontaneity of 
interaction of PDM with BSA. 
The type of quenching mechanism was determined using UV-visible absorption spectroscopy. 
Quenching usually occurs either by static or dynamic mode. Static quenching refers to fluoro-
phore–quencher complex formation and the dynamic quenching refers to a process that the 
fluorophore and the quencher come into contact during the transient existence of the excited 
state. However, the formation of non-fluorescence ground-state complex induced the change in 
absorption spectrum of fluorophore. Addition of the BSA to PDM leads to an increase in PDM 
absorption intensity without affecting the position of absorption band (Fig. 4A). It showed the 
existence of static interaction between BSA and the complexes.  
Spectrofluorimetric spectral behaviour of PDM-BSA complex 
The interaction of PDM with BSA was also examined by fluorescence titration. The fluorescence 
emission spectra of BSA in the presence and absence of various concentration of PDM is shown in 
Fig. 5. The maximum emission of BSA is located at 342 nm (λex = 263 nm). The fluorescence 
emission maxima were gradually decreased with increase in concentration of PDM, indicating the 
quenching of fluorescence intensity of BSA upon binding to PDM. This can be attributed to the 
formation of PDM-BSA complex. The results suggest that microenvironment around the chromo-




Fig. 5. Fluorescence spectra of 1.5×10-4 M BSA in presence of CPDM = 0, 5, 10, 15, 20, 25, 30, 35 µmol L
-1. 
Stern-Volmer binding and quenching constant 
To determine the quenching mechanism between BSA and PDM (i.e. dynamic or static 
quenching), the fluorescence quenching data were analyzed using Stern-Volmer equation.  
F0 /
 F = 1+ kq τo [Q] = 1 + Ksv [Q] 
where, F0 and F are the fluorescence intensities of BSA in absence and presence of PDM 
respectively, [Q] is the Concentration of BSA and kq is the quenching rate constant of the 
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Fig. 6 (a) Plot of F0/F versus [Q] and (b) Plot of log [(F0-F)/F] versus log [Q] 
The Ksv is stern-volmer quenching constant, which was determined by linear regression of a plot 
of F0/F vs. [Q] at 25 °C was constructed (Fig. 6a) using the data from fluorescence titration and a 
linear fitting of the data yielded the binding constant 2.4158×104 L M-1 which is good agreement 
with result obtained from CV and UV/vis spectroscopy. The maximum rate constant of collisional 
quenching of various quenchers with biopolymers is about 2.0 x 1010 L s-1 mol-1 [25]. The greater 
value for Kq is obtained (Ksv and kq values calculated were 1.964×10
4 L M-1 and 1.964×1012 L M-1 s-1) 
(R2 = 0.99523) respectively. As temperature increased, the decreasing trend of Kq was in accor-
dance with Ksv’s dependency on temperature, which coincided with a static quenching mechanism. 
The binding of PDM to BSA was reduced as temperature increased, which suggests that the 
fluorescence quenching process may be mainly controlled by static quenching mechanism rather 
than dynamic. 
The binding constant and number of binding sites  
The binding constant and number of binding sites for PDM-BSA were determined by the 
following equation [26]: 
log[(F0-F)/F] = log Kb + n log [Q] 
where, Kb is binding constant and n is number of binding sites in base pair units respectively. The 
values of n and Kb can be determined from the slope and intercept of the double logarithm re-
gression curve log [(log [(F0 - F)/F] vs. log [Q]) (Fig. 6b). The binding constant value 5.43×104 L M
-1 
(R2 = 0.99879) and values of n is found to be 1.2  1.0, indicating that there is one independent 
class of binding sites in BSA for PDM. The free energy change, ΔG0 (at 27 °C) was evaluated from Kb 
using the relationship ΔG0 = -2.303RT log Kb and its value was found to be -27.016 kJ M
-1 indicating 
the spontaneity of the reaction. 
Molecular modeling studies  
Molecular docking was performed to study the interaction between PDM and BSA to determine 
the preferred binding site and binding mode. The best confirmation was determined based on 
binding affinity and RMSD. The binding energy and RMSD was performed by Auto Dock Vina. A 
three dimensional docked structure of PDM on BSA was shown in Fig. 7. These structures were to 
study various inter molecular interaction and to determine the binding energy of the docked 
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complexes. The PDM were docked with receptor BSA using the parameters mentioned above. The 
energy of interaction for PDM-BSA complex was found to be -10.0 kcal mol-1.  
 
 
Fig. 7. Molecular model of the surface and the active site of the complex of PDM (stick) and 
BSA (white surface) 
Viscometer measurement 
Viscometric technique is an effective tool in clarifying the mode of interaction of small 
molecules with BSA under the physiological condition. In general, intercalation (in-binding mode) 
causes an increase viscosity of BSA solution due to lengthening the BSA widened to accommodate 
the bonded molecule [27]. The reverse can be taken for the electrostatic interaction. The value of 
relative specific viscosity (η/η0)
1/3 vs. [BSA]/[PDM] were plotted (Fig. 8). However, the relative 
viscosity of BSA dependence upon the concentration of PDM, the value of [BSA]/[PDM] is 
decreased. This behaviour indicates that the binding mode between BSA and PDM should be non-
classical intercalation or groove mode via hydrophobic interaction. 
 
Fig. 8. Plot of [BSA/PDM] vs. (η/η0)
1/3  
Conclusions 
In this work, the interaction of PDM with BSA was studied by voltammetric, spectroscopic and 
viscometric methods. In voltammetric studies, it was observed that the presence of BSA in a 
solution of perazine dimalaete reduces the equilibrium concentration of free perazine dimalaete 
and produces a voltammetric inactive complex. Both electrostatic interactions and minor groove 
binding modes were deduced from the results of different methods applied to the system, 
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although groove binding seemed to be predominant. Meanwhile, the experimental results indicate 
that the quenching mechanism of fluorescence of BSA by PDM is a static quenching procedure and 
the binding reaction is spontaneous. This work provides some significant information to clinical 
research about PDM and the theoretical basis for new drug designing. 
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